SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP – Ligand Pharmaceuticals Incorporated Transaction History
SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP portfolio value:
$7.39M
portfolio value
SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP quarter portfolio value change:
-3.49%
quarter
Ligand Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.14% | -118 shares | -278K | $86.11 | 85.85K |
| Q2 2022 | share | Decrease | -0.99% | -859 shares | -2.09M | $89.22 | 85.97K |
| Q1 2022 | share | Decrease | -0.64% | -558 shares | -3.73M | $112.49 | 86.83K |
| Q4 2021 | share | Decrease | -7.47% | -7.05K shares | 341K | $156.16 | 87.39K |
| Q3 2021 | share | Decrease | -4.01% | -3.94K shares | 250K | $139.32 | 94.44K |
| Q2 2021 | share | Decrease | -3.45% | -3.51K shares | -2.62M | $131.19 | 98.38K |
| Q1 2021 | share | Increase | +4.47% | 4.35K shares | 5.83M | $152.45 | 101.89K |
| Q4 2020 | share | Increase | +32.30% | 23.81K shares | 2.67M | $99.45 | 97.54K |
| Q3 2020 | share | Increase | 0.00% | 73.72K shares | 7.02M | $95.32 | 73.72K |